dc.contributor.author | Palanduz, Şükrü | |
dc.contributor.author | Çefle, Kıvanç | |
dc.contributor.author | Öztürk, Şükrü | |
dc.contributor.author | Nalçacı, Meliha | |
dc.contributor.author | Suer, İlknur | |
dc.contributor.author | Sırma Ekmekci, Sema | |
dc.contributor.author | Aday, Aynur | |
dc.contributor.author | Bayrak, Ayşe Gül | |
dc.date.accessioned | 2021-12-10T13:17:04Z | |
dc.date.available | 2021-12-10T13:17:04Z | |
dc.identifier.citation | Suer İ., Sırma Ekmekci S., Aday A., Bayrak A. G. , Çefle K., Öztürk Ş., Nalçacı M., Palanduz Ş., "CEBPA c.584589dup p.His195Pro196dup variant in myeloid malignancies", The Virtual Conference on Current Challenges in Hematology (C-HEM2021), 18 - 19 Mart 2021 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_fc494bcd-26b8-4e29-8c0b-b495a5ecec84 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/175838 | |
dc.language.iso | eng | |
dc.subject | Medicine (miscellaneous) | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Genetics (clinical) | |
dc.subject | Fundamentals and Skills | |
dc.subject | General Health Professions | |
dc.subject | Pathophysiology | |
dc.subject | Family Practice | |
dc.subject | Internal Medicine | |
dc.subject | Assessment and Diagnosis | |
dc.subject | General Medicine | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Klinik Tıp | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | GENETİK VE HAYAT | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıbbi Genetik | |
dc.subject | Genetics | |
dc.title | CEBPA c.584589dup p.His195Pro196dup variant in myeloid malignancies | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.contributor.firstauthorID | 2630144 | |